StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical total assets

Total assets on the balance sheet at the end of each period.

VitaSpring Biomedical's total assets was $14.82K at Jul 31, 2026. For fiscal 2026 it was $14.68K, up 2.1% from the year before. The highest annual figure on record is $3.60M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2026Jan 31, 2026$14.68K+2.1%
FY2025Jan 31, 2025$14.38K-89.5%
FY2024Jan 31, 2024$137.34K-82.1%
FY2023Jan 31, 2023$765.95K-78.7%
FY2022Jan 31, 2022$3.60M+1802.9%
FY2021Jan 31, 2021$189.40K0.0%
FY2020Jan 31, 2020$189.40K–
FY2019Jan 31, 2019$0-100.0%
FY2018Jan 31, 2018$1.87K–
FY2017Jan 31, 2017$0–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jul 31, 2026$14.82K-12.9%
Q1 FY2027CQ1 2026Apr 30, 2026$11.43K-4.0%
Q4 FY2026CQ4 2025Jan 31, 2026$14.68K+2.1%
Q3 FY2026CQ3 2025Oct 31, 2025$16.47K-71.8%
Q2 FY2026CQ2 2025Jul 31, 2025$17.02K-73.5%
Q1 FY2026CQ1 2025Apr 30, 2025$11.91K-90.9%
Q4 FY2025CQ4 2024Jan 31, 2025$14.38K-89.5%
Q3 FY2025CQ3 2024Oct 31, 2024$58.38K-78.9%
Q2 FY2025CQ2 2024Jul 31, 2024$64.33K-84.1%
Q1 FY2025CQ1 2024Apr 30, 2024$131.29K-76.1%
Q4 FY2024CQ4 2023Jan 31, 2024$137.34K-82.1%
Q3 FY2024CQ3 2023Oct 31, 2023$277.35K-88.6%
Q2 FY2024CQ2 2023Jul 31, 2023$404.91K-84.3%
Q1 FY2024CQ1 2023Apr 30, 2023$548.54K-79.7%
Q4 FY2023CQ4 2022Jan 31, 2023$765.95K-78.7%
Q3 FY2023CQ3 2022Oct 31, 2022$2.44M+113.5%
Q2 FY2023CQ2 2022Jul 31, 2022$2.58M+269.5%
Q1 FY2023CQ1 2022Apr 30, 2022$2.70M+485.6%
Q4 FY2022CQ4 2021Jan 31, 2022$3.60M+1802.9%
Q3 FY2022CQ3 2021Oct 31, 2021$1.14M+3594.1%
Q2 FY2022CQ2 2021Jul 31, 2021$699.47K+269.3%
Q1 FY2022CQ1 2021Apr 30, 2021$460.51K+42265.1%
Q4 FY2021CQ4 2020Jan 31, 2021$189.40K+15683.2%
Q2 FY2021CQ2 2020Jul 31, 2020$30.98K+2261.1%
Q4 FY2020CQ4 2019Jan 31, 2020$189.40K–
Q3 FY2020CQ3 2019Oct 31, 2019$1.09K-29.3%
Q2 FY2020CQ2 2019Jul 31, 2019$1.20K-27.2%
Q1 FY2020CQ1 2019Apr 30, 2019$1.31K-25.5%
Q4 FY2019CQ4 2018Jan 31, 2019$0-100.0%
Q3 FY2019CQ3 2018Oct 31, 2018$1.54K-22.6%
Q2 FY2019CQ2 2018Jul 31, 2018$1.65K-21.4%
Q1 FY2019CQ1 2018Apr 30, 2018$1.76K-20.3%
Q4 FY2018CQ4 2017Jan 31, 2018$1.87K–
Q3 FY2018CQ3 2017Oct 31, 2017$1.99K–
Q2 FY2018CQ2 2017Jul 31, 2017$2.10K–
Q1 FY2018CQ1 2017Apr 30, 2017$2.21K–
Q4 FY2017CQ4 2016Jan 31, 2017$0–

More VitaSpring Biomedical figures

See a number that looks wrong?